42 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
6 Dec 23
Other Events
7:13am
investigators, the synovial sarcoma community, and our afami-cel team for their diligent efforts in completing the BLA submission. We look forward … to sarcoma patients. Such advancements offer hope and transformative possibilities for the sarcoma patient community, addressing critical unmet needs
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
of the Company's operations on the community and the environment;
page 4 of 13
the desirability of the Company maintaining a reputation for high
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
the Company's business relationships with suppliers, customers and others;
the impact of the Company's operations on the community and the environment
8-K
EX-10.4
hw5lyrovg1p3ai9x1
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.3
t4ixuqwynq 4b
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
EX-10.2
0a00q2t
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
EX-99.1
pzng38wqvpdyh
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-10.4
jjp5v2so6bf4i811g1b
27 Jun 19
Departure of Directors or Certain Officers
8:08am